Preparation method and application of carbonized resin grafted with arginine
By synthesizing and carbing the resin in the blood perfusion adsorption material and grafting arginine on its surface, the problem of insufficient blood compatibility of the resin is solved, significantly improving the biocompatibility and adsorption performance, especially in removing creatinine and Uric acid shows higher efficiency.
Patent Information
- Application Number
- CN202411350503.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-26
- Publication Date
- 2024-12-06
AI Technical Summary
The resin of existing blood perfusion adsorbent materials is insufficient in blood compatibility when in contact with blood, which can easily cause coagulation and hemolysis, and cannot effectively remove toxic substances such as creatinine and uric acid in the blood.
Diethylene benzene and triallyl isocyanurate as composite crosslinking agents to synthesize polystyrene macroporous resins, and carbonized resins are formed through carbonization treatment to increase their strength and pore structure uniformity, and then the resin surface is Polyhydroxyethyl methacrylate envelope treatment was performed, and finally arginine was grafted on the surface of the resin to improve biocompatibility.
It significantly improves the biocompatibility of the resin, reduces the occurrence of coagulation and hemolytic side reactions, and increases the adsorption rate and adsorption amount to water-soluble toxins such as creatinine and uric acid.
Smart Images

Figure BDA0005062222420000081 
Figure BDA0005062222420000082 
Figure BDA0005062222420000083
Abstract
Citation Information
Cited By
Synthesis process of gamma-phase indium selenide
CN119612458A
A synthesis process of γ-phase indium selenide
CN119612458B
